Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tirzepatide and potential use for metabolically healthy obesity.

European journal of internal medicine - 1 Jul 2023

Copur Sidar, Tanriover Cem, Yavuz Furkan, Tuttle Katherine R, Kanbay Mehmet

Abstract excerpt

Metabolically healthy obesity or metabolically healthy overweight (MHO) is best described as being absent of any major metabolic disorder or cardiovascular diseases such as type 2 diabetes mellitus, dyslipidemia, hypertension, and atherosclerotic cardiovascular disease despite being obese or overweight. Nevertheless, MHO is being recognized as an important risk factor for the development of cardiovascular,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Diabetes Mellitus, Type 2
Share to Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metabolic Syndrome

Share to Obesity

Share to Obesity, Metabolically Benign

Share to Overweight

Share to Risk Factors

Source

Identifiers

PMID: 37183081
DOI: 10.1016/j.ejim.2023.05.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tirzepatide and potential use for metabolically healthy obesity.PMID 37183081Read ↗

Metabolically healthy obesity: Misleading phrase or healthy phenotype?Semantic proximity Read ↗

Tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis in Diet-induced Obesity ModelSemantic proximity Read ↗

Tirzepatide for LipodystrophySemantic proximity Read ↗

Treatment of obesity: should we target the individual or society?Semantic proximity Read ↗

Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan.Semantic proximity Read ↗

Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiencySemantic proximity Read ↗

Cardiovascular Outcomes of Tirzepatide vs Semaglutide in Obesity Without Type 2 Diabetes: A Matched Cohort StudySemantic proximity Read ↗

Are there still healthy obese patients?Semantic proximity Read ↗

Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis.Semantic proximity Read ↗

The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity Read ↗

Metabolic and Cardiovascular Implications of a Metabolically Healthy Obesity PhenotypeSemantic proximity Read ↗

Taking a closer look at metabolically healthy obesitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.